Labeler
Supernus Pharmaceuticals, Inc. NDC Codes
Supernus Pharmaceuticals, Inc. lists 12 finished drug products in the FDA NDC Directory under NDC labeler code 17772.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Trokendi XR, Qelbree, Oxtellar XR, Gocovri
- Active ingredients
- Topiramate, Viloxazine hydrochloride, Oxcarbazepine, Amantadine
- NDC labeler codes
- 17772
- Strengths
- Viloxazine hydrochloride 100 mg/1; Viloxazine hydrochloride 150 mg/1; Viloxazine hydrochloride 200 mg/1; Amantadine 68.5 mg/1; Amantadine 137 mg/1; Topiramate 25 mg/1; Topiramate 50 mg/1; Topiramate 100 mg/1; Topiramate 200 mg/1; Oxcarbazepine 150 mg/1; Oxcarbazepine 300 mg/1; Oxcarbazepine 600 mg/1
- Dosage forms
- Capsule, Extended release, Tablet, Capsule, Coated pellets
- Routes
- Oral
- Drug classes (FDA established)
- Norepinephrine Reuptake Inhibitor, Anti-epileptic Agent, Influenza A M2 Protein Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 48
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Qelbreeviloxazine hydrochloride | Viloxazine hydrochloride 100 mg/1 | Capsule, Extended releaseOral | 17772-131 | 17772-0131-0117772-0131-0717772-0131-30+2 more | — |
| Qelbreeviloxazine hydrochloride | Viloxazine hydrochloride 150 mg/1 | Capsule, Extended releaseOral | 17772-132 | 17772-0132-0117772-0132-0717772-0132-30+2 more | — |
| Qelbreeviloxazine hydrochloride | Viloxazine hydrochloride 200 mg/1 | Capsule, Extended releaseOral | 17772-133 | 17772-0133-0117772-0133-0717772-0133-30+2 more | — |
| Gocovriamantadine | Amantadine 68.5 mg/1 | Capsule, Coated pelletsOral | 17772-085 | 17772-0085-2117772-0085-60 | — |
| Gocovriamantadine | Amantadine 137 mg/1 | Capsule, Coated pelletsOral | 17772-170 | 17772-0170-2117772-0170-60 | — |
| Trokendi XRtopiramate | Topiramate 25 mg/1 | Capsule, Extended releaseOral | 17772-101 | 17772-0101-0117772-0101-0717772-0101-10+2 more | — |
| Trokendi XRtopiramate | Topiramate 50 mg/1 | Capsule, Extended releaseOral | 17772-102 | 17772-0102-0117772-0102-0717772-0102-10+2 more | — |
| Trokendi XRtopiramate | Topiramate 100 mg/1 | Capsule, Extended releaseOral | 17772-103 | 17772-0103-0117772-0103-0717772-0103-10+2 more | — |
| Trokendi XRtopiramate | Topiramate 200 mg/1 | Capsule, Extended releaseOral | 17772-104 | 17772-0104-0117772-0104-0717772-0104-10+2 more | — |
| Oxtellar XRoxcarbazepine | Oxcarbazepine 150 mg/1 | TabletOral | 17772-121 | 17772-0121-0117772-0121-0717772-0121-10 | — |
| Oxtellar XRoxcarbazepine | Oxcarbazepine 300 mg/1 | TabletOral | 17772-122 | 17772-0122-0117772-0122-0717772-0122-10 | — |
| Oxtellar XRoxcarbazepine | Oxcarbazepine 600 mg/1 | TabletOral | 17772-123 | 17772-0123-0117772-0123-0717772-0123-10 | — |
Supernus Pharmaceuticals, Inc.: common questions
- What is Supernus Pharmaceuticals, Inc.'s NDC labeler code?
- 17772. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Supernus Pharmaceuticals, Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.